DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee

Hepatology

Volumn 33, Issue 2, 2001, Pages 448-454

  Pancholi, Preeti ^a   Lee, Dong Hun ^a   Liu, Qingyan ^a   Tackney, Charles ^a   Taylor, Patricia ^a   Perkus, Marion ^b   Andrus, Linda ^a   Brotman, Betsy ^a,c   Prince, Alfred M ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b Virogenetics Inc   (United States)

^c Liberian Institute for Biomedical Research   (Liberia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHIMPANZEE; CHRONIC DISEASE; CHRONIC HEPATITIS; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOTHERAPY; MALIGNANT TRANSFORMATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0035140812     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.21594     Document Type: Article

References (24)

1. Hepatitis B virus infection and primary hepatocellular carcinoma
2. Efficacy of immunotherapy with vaccination against hepatitis B virus on virus B multiplication
3. Specific vaccine therapy in chronic hepatitis B infection
4. Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice
5. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state
6. Recombinant vaccinia virus expressing Pre-S/S protein of duck hepatitis B virus and its preliminary use for treatment of persistent infection
7. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein
8. Protective efficacy of DNA-based immunization against HBV in newborn chimpanzees
9. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells
10. NYVAC: A highly attenuated strain of vaccinia virus
11. Methodology of using vaccinia virus to express foreign genes in tissue culture
12. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system
13. Detection of PCR products: Quantitation and analysis
14. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment
15. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus
16. Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine
17. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
18. Hepatitis B virus transgenic mice: Models of viral immunobiology and pathogenesis
19. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
20. Viral clearance without destruction of infected cells during acute HBV infection
21. Viral clearance without destruction of infected cells during acute HBV infection
22. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection
23. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice
24. Control of infections by NK cells